Archives
-
A-769662: AMPK Evidence, Scope and Limits
2026-10-06
A source-grounded overview of A-769662 as an AMPK activator, emphasizing how its reported effects inform energy-stress and autophagy research, why AMPK activation does not always predict increased autophagy, and where evidence quality and model limitations constrain interpretation.
-
BV6: IAP Antagonist Evidence and Research Context
2026-10-06
BV6 is a Smac-mimetic IAP antagonist studied as a tool for probing apoptosis, cancer-cell sensitization and disease mechanisms. The supplied evidence includes supplier-reported cell and animal findings, but no supplied peer-reviewed study directly evaluates BV6. A 2025 ovarian-cancer muscle study provides useful pathway context while also showing why apoptotic markers alone do not establish causality.
-
Filipin III: Cholesterol Detection and Evidence
2026-10-05
Filipin III is a polyene macrolide antibiotic used as a cholesterol-binding probe for membrane studies. Its fluorescence and sterol-selective membrane effects support cholesterol detection in membranes, but the signal is a proxy rather than a direct measure of total cholesterol.
-
L-Ornithine in Liver–Brain Axis Research
2026-10-05
A source-grounded overview of L-Ornithine as a urea cycle intermediate in liver–brain axis research, examining the 2025 realgar-toxicity study, mechanistic evidence, conceptual applications, translational limits, and supplier-data boundaries.
-
Nelfinavir Mesylate: From Viral Protease to Proteostasis
2026-10-04
Nelfinavir Mesylate is an established HIV-1 protease inhibitor with a newer research connection to DDI2, NFE2L1, and ferroptosis biology. This evidence-focused analysis explains what the findings establish, where interpretation remains limited, and how the compound can frame questions across HIV infection research and cellular proteostasis.
-
JC-1 Mitochondrial Membrane Potential Assay
2026-10-03
The JC-1 Mitochondrial Membrane Potential Assay Kit provides a ratiometric proxy for mitochondrial membrane potential changes through red-to-green fluorescence. It can support apoptosis assay and mitochondrial function analysis, but it does not independently identify apoptosis or establish pathway causality.
-
Early Pheromones Rewire C. elegans Neurodegeneration
2026-10-01
Peng et al. show that pheromone exposure during the L1 stage can permanently remodel neuronal signaling and accelerate neurodegeneration in adult C. elegans. Their work identifies complementary ascr#3 and ascr#10 pathways linking ASK and ASI sensory neurons to AIA interneurons, insulin-like signaling, and neuronal autophagy.
-
DAPT (GSI-IX) in Corneal Cell Fate Assays
2026-10-01
DAPT (GSI-IX) offers a practical way to interrogate γ-secretase-dependent Notch and APP processing in controlled cell systems. This guide translates a corneal epithelial culture study into dose-finding, workflow, troubleshooting, and disease-model strategies without treating one concentration as universally optimal.
-
GLP-1 (9-36) amide: Assay Workflow Guide
2026-09-30
Learn how to use GLP-1 (9-36) amide as a controlled pharmacological perturbation in cAMP, receptor cross-talk, and metabolic assays. The workflow emphasizes fresh handling, orthogonal controls, and careful separation of product-specific observations from findings reported for related antagonists.
-
ABT-737: Apoptosis Beyond the Cancer Cell
2026-09-30
ABT-737 is more than a potent BH3 mimetic inhibitor: it is a mechanistic probe for testing how BCL-2 family dependence shapes cancer-cell fate. This thought-leadership article connects its established apoptosis biology with emerging questions about ischemic injury, senescence, and regeneration while defining the limits of cross-domain translation.
-
Z-YVAD-FMK for Caspase-1 Mechanism Studies
2026-09-29
Z-YVAD-FMK enables targeted separation of caspase-1-driven pyroptosis, inflammatory cytokine release, and overlapping apoptotic signals. This workflow combines practical dosing controls with recent gasdermin evidence to improve assay interpretation in cell, cancer, and exploratory avian models.
-
Gestational Polystyrene Nanoplastics and Male Reproduction
2026-09-29
This 2026 Environment International study integrates testicular transcriptomics, serum metabolomics, and reproductive pathology to propose a partial adverse outcome pathway linking gestational polystyrene nano-plastics exposure with reproductive impairment in adult male offspring. Its principal contribution is a multi-level mechanistic framework centered on arachidonic acid, reactive oxygen species, palmitic acid, and lysophosphatidylcholine changes rather than a single molecular endpoint.
-
Chicken Gasdermins Reveal Caspase-Driven Pyroptosis
2026-09-28
The reference study establishes a mechanistic map of chicken gasdermin activation, showing that chCASP1 cleaves chGSDMA whereas chCASP3 and chCASP7 can cleave chGSDMA and chGSDME. Its combination of cleavage-site analysis, cell-based toxicity assays, antibacterial testing, and infection models extends pyroptosis research beyond mammalian systems and provides a framework for studying avian inflammatory cell death.
-
Streptavidin-Cy3 for Reliable Assay Workflows
2026-09-28
Learn how Streptavidin-Cy3 (SKU K1079) can support fluorescent detection of biotinylated targets in cell-based research without confusing molecular labeling with a direct viability measurement. This practical guide covers assay fit, protocol considerations, interpretation, and product-selection criteria.
-
CHI3L1-IN-5: Astrocyte Aβ Clearance Workflows
2026-09-27
CHI3L1-IN-5 (Compound Z17) lets researchers test whether CHI3L1-driven inflammation and impaired astrocyte amyloid handling can be shifted together. This practical guide pairs NF-κB signaling measurements with Aβ uptake and lysosomal readouts, while separating reported evidence from suggested starting conditions.